SANDOZ AMPHETAMINE XR

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: f3e6a4024d2ed30c
Drug Approval Canada Name: SANDOZ AMPHETAMINE XR
Product Name: SANDOZ AMPHETAMINE XR
Status: Marketed
Status Date: 2016-12-22
Original Market Date: 2016-12-22
Din: 02457288
Drug Class: Human
Dosage Form: Capsule (Extended Release)
Route Of Administration: Oral
Schedule: Schedule G (CDSA I)
Ahfs: 28:20.04
Atc Original: N06BA01 AMFETAMINE
Atc Name: n 06 ba 01
Aig Number: 0161310001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

MIXED SALTS AMPHETAMINE

5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f3e6a4024d2ed30c

Type

Standard